Browse by author
Lookup NU author(s): Professor Neil PerkinsORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
It is only recently that the full importance of nuclear factor-kappa B (NF-kappa B) signalling to cancer development has been understood. Although much attention has focused on the upstream pathways leading to NF-kappa B activation, it is now becoming clear that the inhibitor of NF-kappa B kinases (IKKs), which regulate NF-kappa B activation, have many independent functions in tissue homeostasis and normal immune function that could compromise the clinical utility of IKK inhibitors. Therefore, if the NF-kappa B pathway is to be properly exploited as a target for both anticancer and anti-inflammatory drugs, it is appropriate to reconsider the complex roles of the individual NF-kappa B subunits.
Author(s): Perkins ND
Publication type: Review
Publication status: Published
Journal: Nature Reviews. Cancer
Print publication date: 19/01/2012
ISSN (print): 1474-175X
ISSN (electronic): 1474-1768
Publisher: NATURE PUBLISHING GROUP